Stephen Ubl, the leader of the drug industry’s powerful Washington, DC, lobbying group PhRMA, plans to step down, Endpoints News has learned from sources familiar

Gilead Sciences has dedicated around $11 billion so far this year to three acquisitions meant to bolster its pipelines in cancer and immunology. The pharma

After a flashy debut during the height of the Covid-19 pandemic, Talkspace, like many other virtual mental health companies, struggled to keep the momentum going.

Shah Capital has fired another broadside at vaccine firm Novavax, accusing its board and management of a “destruction in shareholder value.”

A startup developing a one-time treatment that is intended to rewind the clock on dying cells announced a major influx of funding. Life Biosciences, a